drugset / Trial / NCT06326996

Thiamine Intervention and Coronary Artery Bypass Grafting

NCT06326996

RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to gain a better understanding of the association between brain changes and cognitive deficits in coronary heart disease (CHD) patients undergoing coronary artery bypass grafting (CABG) and whether a low-cost thiamine intervention can be used to reduce post-CABG cognitive issues in CHD subjects.

Timeline

Start
2024-10-10
Primary completion
2026-06-30
Completion
2026-09-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Thiamine Other / unclassified